subject area of Pharmacokinetics and Exposure-Response of Vosoritide in Children with Achondroplasia. Journal Article Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study. Journal Article
